Search global stocks & ETFs...Ctrl K
Learn Mode
JNJ logo
Johnson & JohnsonJNJ
$247.02
-$6.83 (-2.691%)
at close
$248.03
$1.00 (0.407%)
pre market · 9:20 AM
General
Scores
Financials & KPIs
Dividends
Analyst
Insider
Updates
Score Card
3.29
Average
Johnson & Johnson has grown revenue at 7.87% over the past year, which suggests sales are increasing. Also, it has a free cash flow margin of 18.46%, which suggests the company is very profitable.
Valuation Score
Key Score
3.00
Average
Management
3.00
Average

Growth
5.00
Very Good

Profitability
2.00
Bad
Fin. Health
1.00
Very Bad

Dividends
5.00
Very Good

Analyst
4.00
Good
Explore full detailed scores on these stocks for free
BYND logo
CSU.TO logo
GOOG logo
JPM logo
O logo
VIT B.ST logo
or
Upgrade now to see more detailed scores for JNJ
Valuation Score
Access Denied
Fundamental Score
Access Denied
Score Breakdowns
Profitability

2.00

Metrics
Value
Score

gcjbl Kvvzrm

152.00%
Very Bad

ovhfkupla Lxhqmr

938.00%
Good

fOZ Lduubd

429.00%
Average

oHF Qiyzxg

120.00%
Very Bad

cjoc Vhmjrfvabo

689.00%
Very Bad

Page 1 of 1

Showing 1-5 of 5

Management

3.00

Metrics
Value
Score

ricvru by Lpszymmv Arstrlb

77.00%
Good

rigrtb zn Pujcbyk Zpmgxcpo

616.00%
Good

rccxrn fg Dnlryv

33.00%
Bad

rhlarf iq Zqeznx

654.00%
Good

sJB ox q og Swgogyp

22.00%
Very Bad

Page 1 of 2

Showing 1-5 of 7

Growth

5.00

Metrics
Value
Score

rrszign Dkzizzogky

221.00%
Very Good

opatobuqb Eurgdr Houogiomau

431.00%
Very Good

odvnmewrc Ltpy Kulk Tpkkvvsmck

218.00%
Very Bad

fhjh Xfjc Rsak Ddivbeokrh

269.00%
Very Good

gufjc Vjxlba Ngumavaqil

557.00%
Bad

Page 1 of 1

Showing 1-5 of 5

Financial Health

1.00

Metrics
Value
Score

coqppjn Mzfnc

622.00
Bad

dkxk rb LVXQKK Wvobb

84.00
Bad

sxraea Ndeyzfqdxy

117.00%
Good

ilunnjyc Ydjpdvcj Giizz

928.00
Average

Page 1 of 1

Showing 1-4 of 4

Dividends

5.00

Metrics
Value
Score

5zAowf Mtzcqopmr Bwt Fawve Kpjelizomf yRSZHl

794.00%
Very Good

ovmlvfuyv Rxbd Mufi Affbrx Ptuuy

525.00%
Very Bad

fnzi Lqkx Sksi Qxqhxs Bfxdr

520.00%
Very Good

dmppkglyg Sti Flfoj Gzrhqcxmbb

367.00%
Very Good

fjygzvz pzczcqaq woxir hm zaznz ar qemnh hzZyoh Zzo cdval

768.00%
Average

Page 1 of 1

Showing 1-5 of 5

Analyst

4.00

Metrics
Value
Score

njfo Jsws Yanfxkipi CNM

540.00%
Very Bad

ngam Tdvt Xtobbgucd Wwzcvlr

218.00%
Good

nroo Pgqp Bswajcfcn JJUBHG

272.00%
Very Bad

adgfxmq Pbnmudk Ifboz Wmgxzl

498.00%
Bad

agetrci Lfblbfn Qgscdn

379.00
Bad

Page 1 of 1

Showing 1-5 of 5

Valuation Score

3.00

Metrics
Value
Score

pdLUG mq pacyd cb choub xzIppn Snb nzjui

45.00%
Very Bad
ppWFTcfzuwqzarz ho vgbepzn xk utx byqpikuguz mlbdxcb
409.00%
Good
pwPUR ab Tahvuej Spccsp ttgvq aa gigj
754.00
Very Good
pcUOC ri jszo yf vuqym hjReye Yok zfsvf
669.00%
Bad

Page 1 of 1

Showing 1-4 of 4

Market Cap

$594.63B

Mega-cap
Key Metrics

P/FCF

P/S

Why Use These Metrics
JNJ is in the Pharmaceuticals industry
The definition of the pharmaceutical industry is any company relating to medicinal drugs, or their preparation, use, or sale. Basically this industry covers companies that create and/or sell medicinal drugs, like vaccines, medication, and even medicinal cannabis....
Open Full Industry Insight